Related Experiment Video
Updated: Aug 20, 2026

Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment
Published on: March 24, 2026
Maternal serum interleukin-1 beta, -6 and -8 levels and potential determinants in pregnancy and peripartum
Gundula Hebisch1, Peruka M Neumaier-Wagner, Renate Huch
1Department of Obstetrics, Zurich University Hospital, Switzerland. g.hebisch@gynosuisse.ch
Aims:
To measure maternal serum interleukins (IL) in pregnancy, delivery and early puerperium, and to identify their potential determinants.
Methods:
Prospective longitudinal measures of serum IL-1 beta, IL-6 and IL-8 in 38 healthy pregnant women at antenatal visits, through labor and delivery, with clinical correlates (infection, vaginal hemorrhage and anemia) recorded by questionnaire.
Results:
Pregnancy IL levels remained consistently low. IL-1 beta increased shortly before delivery, then returned to pregnant levels, except where blood loss exceeded 500 ml. IL-6 and IL-8 rose at labor onset and exceeded pregnancy levels through postpartum day three. Postpartum IL-6 was higher after non-elective cesarean section than after spontaneous delivery (P < 0.0001), and where blood loss exceeded 500 ml. IL-6 and IL-8 were higher with systemic infection during delivery (P < 0.0001) and on postpartum day one (P < 0.05); IL-8 was higher in anemia (delivery: P < 0.005; postpartum day 1: P < 0.05). Differences due to delivery mode and systemic infection remained significant after correction for other conditions.
Conclusions:
Labor-dependent inflammation increases all IL levels at delivery. Further studies with larger sample sizes are required to establish reference values differentiating physiology from pathology as an aid to peripartum management.